Prognostic value of FOXP3 and TGF-β expression in both peripheral blood and lymph nodes in patients with B-Non Hodgkin’s lymphomaFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 24 September 2013

References

• Nadia M, Iman G, Iman A: cancer pathology registry and time trend analysis, NCI Egypt 2007.
   Google Scholar
• Elattar IA, Hassan NM, Lamee MM, Elbasmy AA. Cancer Profile at the National Cancer Institute, Egypt, 2002–2003. J Clin Oncol 2005 (ASCO Annual Meeting Proceedings.); 23: 9653–614.
   Google Scholar
• C.A.ClarkeS.L.GlaserChanging incidence of non-Hodgkin lymphomas in the United StatesCancer94200220152023
   PubMed Web of Science ®Google Scholar
• J.DrachS.SeidlH.KaufmannTreatment of mantle cell lymphoma: targeting the microenvironmentExpert Rev Anticancer Ther52005477485
   PubMed Web of Science ®Google Scholar
• D.De JongMolecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factorsJ Clin Oncol23200563586363
   PubMed Web of Science ®Google Scholar
• S.MontiK.J.SavageJ.L.KutokMolecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory responseBlood105200518511861
   PubMed Web of Science ®Google Scholar
• S.G.ZhengJ.H.WangJ.D.GrayH.SoucierD.A.HorwitzNatural and induced CD4+CD25+ cells educate CD4+CD25-cells to develop suppressive activity: The role of IL-2, TGF-beta and IL-10J Immunol172200452135221
   PubMed Web of Science ®Google Scholar
• W.J.ChenJ.E.KonkelTGF-β and ‘Adaptive’ Foxp3 regulatory T cellsJ Mol Cell Biol220103036
   PubMed Web of Science ®Google Scholar
• D.A.HorwitzS.G.ZhengJ.D.GrayThe role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsetsJ Leukoc Biol742003471478
   PubMed Web of Science ®Google Scholar
• R.H.SchabowskyS.MadireddiR.SharmaE.S.YolcuH.ShirwanTargeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapyCurr Opin Investig Drugs8200710021008
   PubMed Web of Science ®Google Scholar
• A.Lopez-GuillermoE.MontserratF.BoschApplicability of the International index for aggressive lymphomas to patients with low-grade lymphomaJ Clin Oncol12199413431348
   PubMed Web of Science ®Google Scholar
• P.Solal-CelignyP.RoyP.ColombatFollicular Lymphoma International Prognostic IndexBlood104200412581265
   PubMed Web of Science ®Google Scholar
• A.BoyumIsolation of leukocytes from human bloodScand J Clin Invest211986929
   Google Scholar
• M.M.LedermanE.ConnickA.LandayD.R.KuritzkesJ.SpritzlerSt. Clair M, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315J Infect Dis17819987079
   PubMed Web of Science ®Google Scholar
• H.ZhangP.YangH.ZhouQ.MengX.HuangInvolvement of Foxp3-expressing CD4+ CD25+ regulatory T cells in the development of tolerance induced by transforming growth factor-β2-treated antigen-presenting cellsImmunology1242008304314
   PubMed Web of Science ®Google Scholar
• L.VaickusE.D.BallK.A.FoonImmune markers in hematologic malignanciesCritical Rev Oncol/Hematol111991267297
   PubMed Web of Science ®Google Scholar
• R.BoomC.J.SolM.M.SalimansC.L.JansenP.M.Wertheim-van DillenJ.van der NoordaaRapid and simple method for purification of nucleic acidsJ Clin Microbiol281990495503
   PubMed Web of Science ®Google Scholar
• G.M.RuppJ.LockerPurification and analysis of RNA from paraffin embedded tissuesBiotechniques619885660
   PubMed Web of Science ®Google Scholar
• B.A.PayerT.ReibergerK.RutterS.BeinhardtA.F.StaettermayerM.Peck-RadosavljevicSuccessful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patientJ Clin Virol492010131133
   PubMed Web of Science ®Google Scholar
• B.GoergenS.JacobsP.SymmonsE.HomesK.-H.Meyer zum BuschenfeldeG.GerkenQuantification of HCV replication using one step competitive RT-PCR and a solid phase colorimetric detection methodJ Hepatol211994678682
   Web of Science ®Google Scholar
• M.W.BerchtoldA simple method for direct cloning and sequencing of cDNA by the use of a single oligonucleotide and oligo (dT) in a polymerase chain reactionNucleic Acids Res171989453459
   PubMed Web of Science ®Google Scholar
• A.OverberghD.GiuliettiB.ValckxR.DecallonneV.BouillonC.MathieuThe use of real-time reverse transcriptase PCR for the quantification of cytokine gene expressionJ Biomol Tech1420033343
   PubMedGoogle Scholar
• N.A.SaundersQuantitative Real- Time PCR. In: Real- time PCR: An Essential Guide. Edwards K, Logan J, Saunders N, London HorizonBioscience62004303333
   Google Scholar
• J.R.BrodyS.E.KernHistory and principles of conductive media for standard DNA electrophoresisAnal Biochem3332004113
   PubMed Web of Science ®Google Scholar
• B.D.ChesonS.J.HorningB.CoiffierEt al. Report of an international workshop to standerize response criteria for non-hodjkin lymphoma: NCI Sponsored international Working groupJ Clin Oncol17199912441253
   PubMed Web of Science ®Google Scholar
• Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 11.
   Google Scholar
• Burger JA, Ghia P, Rosenwald A, Cappio FC. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009; 114: 152–3367-75.
   Google Scholar
• N.MazherZ.IqbalN.AslamN.MazherInt J Pathol81201019
   Google Scholar
• L.YangX.XuC.PengJ.WeiZ.SongZ.CongPrognostic values of serum LDH and β2-MG in patients with non-Hodgkin’s lymphoma Chinese-GermanJ Clin Oncol82009353355
   Google Scholar
• Yang ZZ, Anne J. Novak, Mary J. Stenson, Thomas E. Witzig and Stephen M. Ansell. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4 + T cells in B-cell non-Hodgkin lymphoma. 2006 107: 3639–3646.
   Google Scholar
• Lin H, Sun XF, Zhen Z, Xia Y, Yu J, Lin TY, et al. Correlation between peripheral blood CD4+ CD25high CD127low regulatory T cells and clinical characteristics of patients with non-Hodgkin lymphoma. Chinese J of Cancer 2009;28:59–64.
   Google Scholar
• L.LaurentiM.M.MinerviniS.DeaglioL.BonelloL.De MartinoL.De PaduaRegulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive diseaseLeuk Res352011363368
   Web of Science ®Google Scholar
• Mittal VS, Marshall NA, Duncan L, Culligan DJ, Barker RN, Mark A. Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma. 2008; 111: 5359–70.
   Google Scholar
• L iu L, Yao JX, Ding Q, Huang SA. CD4+ CD25 high regulatory T cells in peripheral blood of patients with B cell non-Hodgkin’s lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006; 14:119–22.
   Google Scholar
• SchmittM, Giannopoulos K, http://www.ncbi.nlm.nih.gov/pubmed?term=%22 Schmitt%20 M%22%5BAuthor%5D, Kowal M, Wlasiuk P, Bojarska-Junak A, Chen J, et al. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia. Oncol Rep. 2008 Sep; 20(3):677-82.
   Google Scholar
• M.L.ChenM.J.PittetL.GorelikRegulatory T cells suppress tumor-specific CD8 T mcell cytotoxicity through TGF-{beta} signals in vivoProc Natl Acad Sci20051022005419424
   Web of Science ®Google Scholar
• S.B.JakowlewTransforming growth factor-beta in cancer and metastasisCancer Metastasis Rev252006435457
   PubMed Web of Science ®Google Scholar
• J.O.ArmitageM.A.FyfeJ.LewisLong-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimenJ Clin Oncol21984898902
   PubMed Web of Science ®Google Scholar
• M.P.LinkJ.J.ShusterS.S.DonaldsonTreatment of children and young adults with early-stage non-Hodgkin’s lymphomaN Engl J Med337199712591266
   PubMed Web of Science ®Google Scholar
• P.SonneveldM.de RidderH.van der LelieComparison of doxorubcin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-hodjkin lymphoma using CHOP versus CNOP chemotherapyJ Clin Oncol13199525302539
   PubMed Web of Science ®Google Scholar
• F.GhiringhelliC.MenardP.E.PuigMetronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatoryT cells and restoresTand NK effector functions in end stage cancer patientsCancer Immunol Immunother562007641648
   PubMed Web of Science ®Google Scholar
• S.LadoireL.ArnouldL.ApetohPathologic complete response to neoadjuvant chemotherapy of breast carcinoma Is associated with the disappearance of tumor-infiltrating Foxp3+ regulatory T CellsClin Cancer Res14200824132420
   PubMed Web of Science ®Google Scholar
• Menard C, Puig PE, et al. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatoryT cells and restoresTand NK effector functions in end stage cancer patients. Cancer Immunol Immunother 2007;56:641–8.
   Google Scholar
• L.ZhangM.JinK.DermawanS.XiongY.ChuDoes chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cellsMed Hypothesis712008802804
   Web of Science ®Google Scholar
• P.LissoniF.BrivioL.FunagalliG.MessinaS.MagalliG.PorroEffects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory t lymphocytes in cancer patientsAnticancer Res29200918471852
   PubMed Web of Science ®Google Scholar
• C.B.ReederS.M.AnsellNovel therapeutic agents for B cell Lymphoma: developing rational combinationsBlood117201114531462
   Web of Science ®Google Scholar
• Y.X.ShiX.S.ZhangD.G.LiuY.Q.LiZ.Z.GuanW.Q.JiangCD4+CD25+T regulatory cells in peripheral blood of B-NHL patients with or without chemotherapyAi Zheng2352004 May597601
   Google Scholar